Cargando…

Intra-nasal Esketamine Induced Psychotic Disorder in a Post Covid-19 Major Depressive Episode: a case report

Detalles Bibliográficos
Autores principales:	Tang, Julie, Munoz, Thomas, Jolivet, Isabelle, Chappell, Kenneth, Choucha, Walid, Colle, Romain, Verstuyft, Celine, de Lepinau, Jean, Corruble, Emmanuelle, Gasnier, Matthieu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	L'Encéphale, Paris. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169572/ http://dx.doi.org/10.1016/j.encep.2023.05.001

Ejemplares similares

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later
por: Gasnier, Matthieu, et al.
Publicado: (2022)

Anosmia during acute COVID-19 and psychiatric outcomes 4 months later: Results from the prospective COMEBAC cohort
por: Faulet, Théo, et al.
Publicado: (2023)

Psychiatric disorders and long COVID
por: Gasnier, Matthieu, et al.
Publicado: (2022)

P124. Which Patients Will Have Mental Disorders After Hospitalization for COVID-19?
por: Gasnier, Matthieu, et al.
Publicado: (2022)

128. Long Covid and Psychiatric Disorders 4 Months After a Hospitalization for COVID-19: A Cross Sectional Study
por: Gasnier, Matthieu, et al.
Publicado: (2023)

The MAOA rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients
por: Chappell, Kenneth, et al.
Publicado: (2022)

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
por: Jollant, Fabrice, et al.
Publicado: (2023)

Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings
por: Voican, Cosmin Sebastian, et al.
Publicado: (2016)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle, Romain, et al.
Publicado: (2016)

Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response
por: Mesdom, Pierre, et al.
Publicado: (2020)

The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study
por: Deflesselle, Eric, et al.
Publicado: (2018)

The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients
por: Chappell, Kenneth, et al.
Publicado: (2022)

Peripheral tryptophan and serotonin and kynurenine pathways in major depression: A case-control study
por: Colle, R., et al.
Publicado: (2021)

Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal
por: Portal, Benjamin, et al.
Publicado: (2022)

Treating with esketamine nasal, will increase blood pressure?
por: Rosello-Molina, V., et al.
Publicado: (2021)

Blood microbiota and metabolomic signature of major depression before and after antidepressant treatment: a prospective case–control study
por: Ciocan, Dragos, et al.
Publicado: (2021)

Case report: Intranasal esketamine for severe major depressive disorder with psychotic features
por: Carter, Maximilian, et al.
Publicado: (2022)

Psychological distress among outpatient physicians in private practice linked to COVID-19 and related mental health during the second lockdown
por: Frajerman, Ariel, et al.
Publicado: (2022)

Telemedicine use during the COVID-19 lockdown is associated with fewer depressive symptoms among physicians in private practice
por: Frajerman, Ariel, et al.
Publicado: (2023)

Electroconvulsive therapy vs Esketamine among patients with Major Depressive Episode
por: Basto, M. D. R. D. R. F. D. A., et al.
Publicado: (2023)

Santé mentale des médecins libéraux français pendant la deuxième vague de COVID 19
por: Frajerman, Ariel, et al.
Publicado: (2023)

Post-acute COVID-19 syndrome
por: Montani, David, et al.
Publicado: (2022)

Syndrome post-COVID-19()
por: Montani, David, et al.
Publicado: (2023)

Isotretinoin-induced psychotic episode in a 17-year-old adolescent male
por: Elhusein, Bushra, et al.
Publicado: (2020)

Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review
por: Nguyen, Thi Mai Loan, et al.
Publicado: (2023)

Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression
por: Katz, Eva G., et al.
Publicado: (2020)

Managing dissociative symptoms following the use of esketamine nasal spray: a case report
por: Pereira, Sophia, et al.
Publicado: (2020)

Intra-Nasally Administered Oligopeptide Lunasin Acts as a Possible Anti-Psychotic Agent in Mice Models
por: Dzirkale, Zane, et al.
Publicado: (2019)

Neurobiological Approach of Catatonia and Treatment Perspectives
por: Ellul, Pierre, et al.
Publicado: (2015)

Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression
por: Mendez-David, Indira, et al.
Publicado: (2017)

TRANSSEXULISM : ONSET AFTER AN ACUTE PSYCHOTIC EPISODE
por: Banerjee, A., et al.
Publicado: (1997)

Gender differences in first episode psychotic mania
por: Cotton, Sue M, et al.
Publicado: (2013)

Psychotic Episode and Schizophrenia in Slovakian Narcolepsy Database
por: Feketeová, Eva, et al.
Publicado: (2022)

Acute Psychotic Episode Induced by Antimicrobial Treatment
por: Arain, Savera I., et al.
Publicado: (2023)

CT OF THE ENDOCRANIUM IN THE FIRST EPISODES OF PSYCHOTIC DISORDERS
por: Tomcuk, A., et al.
Publicado: (2023)

First psychotic episode due to inmunosupresor medication
por: Corrales, A., et al.
Publicado: (2023)

Delirious episode secondary to rotigotine: the psychotic patch
por: Andreo Vidal, M. A., et al.
Publicado: (2023)

Improvement of functional neurological disorder after administration of esketamine nasal spray: a case report
por: Vendrell-Serres, Júlia, et al.
Publicado: (2021)

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression
por: Chen, Guang, et al.
Publicado: (2022)

Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort
por: El Asmar, K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jf0mgi3vb75j94eshhfunkk69r